No Data
Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
Sage Therapeutics Price Target Raised to $5 From $4 at RBC Capital
RBC Raises Price Target on SAGE Therapeutics to $5 From $4, Keeps Sector Perform, Speculative Risk
Wall Street Analysts Believe Sage Therapeutics (SAGE) Could Rally 42.02%: Here's Is How to Trade
Sage Therapeutics Is Maintained at Overweight by Piper Sandler
Piper Sandler Initiates Sage Therapeutics(SAGE.US) With Buy Rating, Announces Target Price $9
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
